Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma
1997

Low bFGF Levels Linked to Poor Prognosis in Breast Cancer

Sample size: 140 publication Evidence: high

Author Information

Author(s): R Colomer, J Aparicio, S Montero, C Guzman, L Larrodera, H Cortes-Funes

Primary Institution: Hospital Universitario Doce de Octubre

Hypothesis

Do low levels of basic fibroblast growth factor (bFGF) correlate with poor prognosis in breast carcinoma?

Conclusion

Low levels of bFGF in breast carcinoma are associated with a significantly shorter disease-free survival.

Supporting Evidence

  • Low bFGF levels were found in 54% of patients who relapsed compared to 17% who did not.
  • Patients with low bFGF had a significantly shorter disease-free survival.
  • Low bFGF levels correlated with larger tumor size and more advanced disease stage.

Takeaway

If a patient with breast cancer has low bFGF levels, they might have a harder time staying cancer-free after treatment.

Methodology

The study measured bFGF levels in breast tumor cytosols using an immunoassay and followed patients for disease relapse.

Limitations

The study did not assess overall survival as a primary endpoint.

Participant Demographics

The study included 140 patients with breast carcinoma or benign breast conditions, median age 57 years.

Statistical Information

P-Value

0.002

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication